DEFA14A: ESSA Pharma Inc. to Hold Annual General Meeting on March 5, 2025

ESSA Pharma Inc. will hold its annual general meeting on March 5, 2025, with shareholders voting on key proposals including the election of directors and appointment of auditors.

Summary

• ESSA Pharma Inc. will hold its annual general meeting of shareholders on March 5, 2025.
• The meeting will take place at Suite 3500, 1133 Melville St., Vancouver, British Columbia.
• Shareholders of record as of January 8, 2025, are eligible to vote.
• The agenda includes receiving the audited financial statements for the year ended September 30, 2024, setting the number of directors at seven, electing seven directors, an advisory vote on executive compensation, and appointing Davidson & Co LLP as auditors.
• The Board recommends voting FOR all director nominees and FOR Proposals 2-4.
• Shareholders can access meeting materials online at www.sedarplus.com or the company's website.
• Paper copies of the meeting materials can be requested free of charge from Laurel Hill Advisory Group or ESSA Pharma's headquarters.
• The proxy cut-off date for the Meeting is 2:00 p.m. (Pacific Time), on March 3, 2025.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral sentiment focused on procedural matters.

Positives

• Shareholders have multiple avenues to access meeting materials, including online and via mail.
• The board provides clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the agenda and procedures for the upcoming Annual General Meeting, focusing on standard corporate governance matters.

Industry Context

This is a standard proxy statement related to an annual general meeting, a routine event for publicly traded companies to engage with shareholders on key decisions.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting on key proposals.
• The outcome of the votes will impact the composition of the Board of Directors and the selection of the company's auditors.

Next Steps

• Shareholders should review the meeting materials and vote on the proposals by the proxy cut-off date.

Key Dates

Keywords

Annual General Meeting, Proxy Statement, Shareholders, Directors, Auditors, Executive Compensation, Voting, ESSA Pharma